HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats.

Abstract
The aim of this study is to investigate the chemopreventive effects of the synthetic phenolic antioxidant 1-O-hexyl-2,3, 5-trimethylhydroquinone (HTHQ) on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colon carcinogenesis in rats after initiation with 1,2-dimethylhydrazine (DMH) in male F344 rats. Groups of 20-22, 6-week-old male F344 rats were given four subcutaneous injections of 40 mg/kg body wt of DMH during the initial 4 weeks. They were then maintained on powdered basal diet containing 0.03% PhIP alone, PhIP together with 0.5 or 0.125% HTHQ, 0.5 or 0.125% HTHQ alone or basal diet for 32 weeks. A small number (1.1 +/- 1.1/rat) of colon tumors were induced by DMH treatment alone. After initiation with DMH, the number of colon tumors was greatly increased to 8.3 +/- 5.6 by the administration of PhIP. Additional treatment with HTHQ dose-dependently decreased the multiplicity of colon adenocarcinomas to 4.9 +/- 2.8 and 2.6 +/- 1.4 with 0.125 and 0.5%, respectively. This treatment similarly reduced atypical hyperplasias of the ventral prostate. Furthermore, HTHQ significantly reduced the multiplicity of duodenal adenocarcinomas induced by DMH + PhIP or DMH alone. Immunohistochemically, HTHQ was revealed to suppress PhIP-DNA adduct formation in the epithelial cells of the colon and prostate in a separate 2 weeks experiment. The present results clearly showed that HTHQ has chemopreventive potential for PhIP-associated colon and prostate carcinogenesis. The observed inhibition may largely be due to interference with PhIP-DNA adduct formation. In addition, HTHQ has been demonstrated to inhibit duodenal carcinogenesis in the post-initiation stage.
AuthorsMitsuru Futakuchi, Masao Hirose, Katsumi Imaida, Satoru Takahashi, Kumiko Ogawa, Makoto Asamoto, Tokutaro Miki, Tomoyuki Shirai
JournalCarcinogenesis (Carcinogenesis) Vol. 23 Issue 2 Pg. 283-7 (Feb 2002) ISSN: 0143-3334 [Print] England
PMID11872633 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinogens
  • DNA Adducts
  • Hydroquinones
  • Imidazoles
  • 1-O-hexyl-2,3,5-trimethylhydroquinone
  • 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
  • 1,2-Dimethylhydrazine
Topics
  • 1,2-Dimethylhydrazine (pharmacology)
  • Adenocarcinoma (chemically induced, prevention & control)
  • Animal Feed
  • Animals
  • Carcinogens
  • Colonic Neoplasms (chemically induced, prevention & control)
  • DNA Adducts
  • Duodenal Neoplasms (chemically induced, prevention & control)
  • Hydroquinones (pharmacology)
  • Imidazoles
  • Immunohistochemistry
  • Intestinal Neoplasms (chemically induced, prevention & control)
  • Male
  • Pancreatic Neoplasms (chemically induced, prevention & control)
  • Prostatic Neoplasms (chemically induced, prevention & control)
  • Rats
  • Rats, Inbred F344
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: